Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
32,315,113
-
Total 13F shares
-
4,716,023
-
Share change
-
-119,004
-
Total reported value
-
$18,630,449
-
Put/Call ratio
-
6400%
-
Price per share
-
$3.95
-
Number of holders
-
52
-
Value change
-
-$1,607,591
-
Number of buys
-
27
-
Number of sells
-
16
Institutional Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q4 2024
As of 31 Dec 2024,
XBiotech Inc. - Common Shares, no par value (XBIT) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,716,023 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, NORTHERN TRUST CORP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, AMERICAN CENTURY COMPANIES INC, MORGAN STANLEY, and Bank of New York Mellon Corp.
This page lists
52
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.